Clinical Trials Logo
  1. Home
  2. Coronary Artery Disease
  3. NCT05549739
  4. Details
NCT05549739 Clinical Trial

Evaluation of Respiratory Parameters and Functional Capacity in Coronary Artery Patients

Coronary Artery Disease Clinical Trial

Official title:
Evaluation of Respiratory Parameters and Functional Capacity in Coronary Artery Patients

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT05549739
Other study ID # GO 20/298
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date September 23, 2022
Est. completion date November 2022

Study information
Verified date October 2022
Source Hacettepe University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The purpose of this study is to evaluate respiratory parameters and functional capacity in coronary artery patients.

Description:

Decreased pulmonary function as measured by forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), or peak expiratory flow (PEF) has been associated with an increased risk of cardiovascular mortality and morbidity. A low MIP value may generally indicate weak muscle strength and therefore be an indicator of general poor health. Respiratory muscle weakness and decreased respiratory muscle endurance affect exercise tolerance in individuals with chronic disease, including cardiovascular disease. Studies have supported the association of grip strength with frailty, physical activity, diabetes, functional limitation, nutritional status, metabolic syndrome, and mortality. The study will evaluate respiratory parameters and functional capacity in coronary artery patients.

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 30
Est. completion date November 2022
Est. primary completion date November 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 41 Years to 75 Years
Eligibility Inclusion Criteria: - Patients with coronary artery disease - Volunteering to participate in the research Exclusion Criteria: - Having a musculoskeletal problem - Having unstable cardiac disease - Having chronic heart failure (NYHA III-IV) - A history of acute coronary syndrome or surgical revascularization less than 3 months ago - Having arrhythmia - Having the last stage of kidney disease - Having active myocarditis or pericarditis

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Turkey Hacettepe University Ankara

Sponsors (1)
Lead Sponsor Collaborator
Hacettepe University

Country where clinical trial is conducted

Turkey, 

Outcome
Type Measure Description Time frame Safety issue
Primary Six-minute-step test The number of steps the participant climbed up and down is recorded. Day 1
Primary Respiratory muscle strength Respiratory muscle strength will be evaluated using a mouth pressure device. Day 1
Primary Respiratory muscle endurance Respiratory muscle endurance will be evaluated using a constant load test. Day 1
Secondary Pulmonary functions Forced vital capacity (FVC), Forced expiratory volume at one second (FEV1), Peak expiratory flow (PEF) assessment via spirometry. Day 1
Secondary Hand grip strength Hand grip strength is evaluated by a hand dynamometer. Day 1
Secondary Functional Capasity The functional capacity is assessed with The Duke Activity Status Index (DASI). Day 1
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Coronary De Novo Lesions N/A